Sanofi to buy US biopharma group Blueprint for up to US$9.5 billion
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in ...
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in ...
SIGNS of gloom are mounting in the US$9.5 trillion ETF landscape, threatening to expose Wednesday’s (Sep 11) dip buying in ...
HEWLETT Packard Enterprise (HPE) is sounding out investors on Wednesday (Sep 11) for a potential US$9.5 billion debt package to ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2026 The New York Journals. All Rights Reserved.